What to Expect When Starting Semaglutide (Ozempic)
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Introduction
Ozempic (semaglutide injection) is a glucagon-like peptide-1 (GLP-1) receptor agonist approved for the treatment of type 2 diabetes mellitus [1]. Administered as a once-weekly subcutaneous injection, it works by stimulating insulin secretion, suppressing glucagon release, and slowing gastric emptying, which together lower blood sugar and often promote weight loss [2]. Ozempic also has demonstrated cardiovascular benefits, reducing the risk of major adverse cardiovascular events in patients with type 2 diabetes and established cardiovascular disease.
Week-by-week timeline
Starting the Lowest Dose
You will begin at 0.25 mg injected once weekly. This dose is sub-therapeutic — its purpose is to help your body acclimate to the GI effects of GLP-1 receptor agonism, not to achieve full glycemic control [1]. Nausea is the most common side effect, affecting up to 20% of patients during initiation, and typically peaks in the first 1-2 weeks at each new dose level [2]. Other common GI effects include decreased appetite, diarrhea, and occasional vomiting. Blood sugar may begin to decrease modestly even at this low dose.
First Dose Escalation to 0.5 mg
After 4 weeks, the dose increases to 0.5 mg weekly. This is the first therapeutic dose for glycemic control [1]. GI symptoms may briefly recur or intensify with the dose increase but generally settle within 1-2 weeks. You should notice more significant appetite reduction and early weight loss. Fasting and postprandial blood glucose levels will be improving. HbA1c changes are not yet fully apparent at this stage — allow at least 8-12 weeks for meaningful HbA1c reduction.
Escalation to 1 mg and Beyond
Depending on glycemic response, the dose may increase to 1 mg weekly, and potentially to the maximum of 2 mg weekly [1]. The SUSTAIN 6 trial demonstrated a 26% reduction in major adverse cardiovascular events with semaglutide versus placebo in patients with type 2 diabetes [3]. Weight loss becomes more apparent — average weight reduction of 4-6 kg is typical in diabetes trials. HbA1c reductions of 1.0-1.8% are expected at therapeutic doses.
Full Therapeutic Effect
By this stage, semaglutide is at or near its target dose and the full therapeutic effect is established. HbA1c should be measurably improved, appetite and weight are more stable, and GI side effects have largely resolved for most patients [1][2]. Your doctor will check HbA1c (target typically <7%) and may adjust other diabetes medications. The injection becomes a simple weekly routine.
When to call your doctor
Contact your healthcare provider if you experience:
- Severe, persistent abdominal pain — especially if radiating to the back, which may indicate pancreatitis (rare but serious; incidence ~0.3% in clinical trials) [1]
- Signs of allergic reaction: skin rash, swelling of face/lips/tongue, difficulty breathing, or rapid heartbeat [1]
- Persistent vomiting that prevents adequate fluid intake for more than 24 hours, risking dehydration and acute kidney injury [1]
- Symptoms of hypoglycemia (especially if also taking insulin or sulfonylureas): shakiness, sweating, confusion, rapid heartbeat, blurred vision [2]
- Vision changes including blurred vision, flashes of light, or dark spots — may indicate diabetic retinopathy worsening, which has been observed with rapid glucose improvement [1]
Tips for getting started
Inject Ozempic on the same day each week, at any time of day, with or without meals. Rotate injection sites (abdomen, thigh, upper arm) to prevent lipodystrophy. Start with smaller, more frequent meals rather than large portions to minimize nausea — meal size is the most important modifiable factor for reducing GI side effects [1]. Stay well hydrated, especially if experiencing vomiting or diarrhea. Store unused pens in the refrigerator; the pen in use can be kept at room temperature for up to 56 days [1]. Do not mix semaglutide with insulin in the same injection.
Frequently asked questions
More about Semaglutide (Ozempic)
References
- [Regulatory] Ozempic (semaglutide) FDA Prescribing Information. Novo Nordisk. Revised 2024. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209637s020lbl.pdf Accessed 2025-01-15.
- [Regulatory] Semaglutide. StatPearls [Internet]. National Library of Medicine. Updated 2024. https://www.ncbi.nlm.nih.gov/books/NBK603723/ Accessed 2025-01-15.
- [Clinical] Marso SP, Bain SC, Consoli A, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes (SUSTAIN 6). N Engl J Med. 2016;375(19):1834-1844. https://pubmed.ncbi.nlm.nih.gov/27633186/ Accessed 2025-01-15.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: